Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 751 AL 765

Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers

Zhao Y, Yang G.

Neurochem Int. 2021 Mar;144:104974. doi: 10.1016/j.neuint.2021.104974. Epub 2021 Jan 22.

Mitochondrial DNA maintenance disorders in 102 patients from different parts of Russia: Mutational spectrum and phenotypes

Bychkov IO, Itkis YS, Tsygankova PG, Krylova TD, Mikhaylova SV, Klyushnikov SA, Pechatnikova NL, Degtyareva AV, Nikolaeva EA, Seliverstov YA, Kurbatov SA, Dadali EL, Rudenskaya GE, Illarioshkin SN, Zakharova EY.

Mitochondrion. 2021 Mar;57:205-212. doi: 10.1016/j.mito.2021.01.004. Epub 2021 Jan 21.

Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Lockhart D, Staines H, Lees A.

Parkinsonism Relat Disord. 2021 Feb;83:79-85. doi: 10.1016/j.parkreldis.2020.12.024. Epub 2021 Jan 12.

The therapeutic potential of ketone bodies in Parkinson's disease

Thickbroom GW.

Expert Rev Neurother. 2021 Mar;21(3):255-257. doi: 10.1080/14737175.2021.1881483. Epub 2021 Jan 29.

Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson's disease

Janssen Daalen JM, Tosserams A, Mahlknecht P, Seppi K, Bloem BR, Darweesh SKL.

Parkinsonism Relat Disord. 2021 Mar;84:155-163. doi: 10.1016/j.parkreldis.2021.01.005. Epub 2021 Jan 12.

Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson's Disease: An Up-and-Down Sequential Allocation Trial

Yang C, Kang F, Meng W, Dong M, Huang X, Wang S, Zuo Z, Li J.

Clin Interv Aging. 2021 Jan 15;16:129-137. doi: 10.2147/CIA.S291656. eCollection 2021.

A compound heterozygous PINK1-associated juvenile Parkinson's disease with pregnancy in Chinese

Li JY, Li NN, Wang L, Peng JX, Duan LR, Chen CL, Peng R.

J Neurol. 2021 Jun;268(6):2223-2227. doi: 10.1007/s00415-021-10405-z. Epub 2021 Jan 25.

Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities

Angelopoulou E, Paudel YN, Piperi C, Mishra A.

J Biochem Mol Toxicol. 2021 Apr;35(4):e22720. doi: 10.1002/jbt.22720. Epub 2021 Jan 24.

Parkinson's Disease and the COVID-19 Pandemic

Fearon C, Fasano A.

J Parkinsons Dis. 2021;11(2):431-444. doi: 10.3233/JPD-202320.

A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson's Disease

Larson DN, Schneider RB, Simuni T.

J Parkinsons Dis. 2021;11(s1):S27-S34. doi: 10.3233/JPD-202381.

The Dawning of a Brighter Future: Celebrating 10 Years of Journal of Parkinson's Disease

Bloem BR, Brundin P.

J Parkinsons Dis. 2021;11(1):1-2. doi: 10.3233/JPD-219001.

Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert

Chen YS, Shu K, Kang HC.

J Alzheimers Dis. 2021;80(1):53-70. doi: 10.3233/JAD-201141.

The Impact of the Basal Ganglia on Working Memory: Evidence from Parkinson's Disease

Witt K.

Mov Disord. 2021 Jan;36(1):13-15. doi: 10.1002/mds.28358.

Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy

Mahmoudzadeh M, Wallois F, Tir M, Krystkowiak P, Lefranc M.

PLoS One. 2021 Jan 25;16(1):e0245188. doi: 10.1371/journal.pone.0245188. eCollection 2021.

Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism

Chittoor-Vinod VG, Nichols RJ, Schüle B.

Int J Mol Sci. 2021 Jan 21;22(3):1045. doi: 10.3390/ijms22031045.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias